About
PurpleAI became an independent company in October 2024 (in operations since 2019 as part of SK Group) and is a fast-growing medical AI pioneer transforming stroke care through intelligent automation and predictive foresight—enhancing workflow efficiency and diagnostic accuracy to drive better patient outcomes. PurpleAI is continuously expanding its Hyper Insight™ product portfolio across multiple imaging modalities and is pushing into multi-modal data-driven predictive analytics. Its upcoming flagship StrokeShieldAI is designed to anticipate and monitor high-risk complications following initial stroke treatment. By equipping clinicians with real-time foresight, StrokeShieldAI enables earlier intervention, mitigates adverse outcomes, and sets a new standard for stroke care.
Technologies
Keywords
Company Information
- Employees6
- Founded2024
Location
Seoul, Incheon, South Korea